Health Allogene Therapeutics (ALLO) Down 1.6% Since Last Earnings Report: Can It Rebound? December 2, 2022
Biotechnology Editas Medicine to Host Virtual Event to Highlight Initial Clinical Data from the RUBY Trial of EDIT-301 for Severe Sickle Cell Disease December 1, 2022
Biotechnology Why Is CRISPR Therapeutics AG (CRSP) Up 0.2% Since Last Earnings Report? December 1, 2022
Health Blueprint Medicines (BPMC) Up 3.7% Since Last Earnings Report: Can It Continue? December 1, 2022